|
WO2021067388A1
|
|
Poly-dioxanone multi-block copolymer for ocular protein delivery
|
|
WO2021021644A1
|
|
Compositions and methods for treatment of presbyopia
|
|
WO2020214906A1
|
|
Cgrp antagonists for the treatment of medication overuse headache, post-traumatic headache, post-concussion syndrome and vertigo
|
|
AU2013206229A1
|
|
A method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
|
|
AU2012216593A1
|
|
Compositions and methods for transdermal oxybutynin therapy
|
|
AU2010246103A1
|
|
A method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
|
|
US6541504B1
|
|
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
|
|
TWI255717B
|
|
Botulinum toxin implant
|
